Genomic organization of the structural proteins of borna disease virus revealed by a cDNA clone encoding the 38-kDa protein.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMID 8317098)

Published in Virology on July 01, 1993

Authors

J M Pyper1, J A Richt, L Brown, R Rott, O Narayan, J E Clements

Author Affiliations

1: Division of Comparative Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Articles citing this

Genomic organization of Borna disease virus. Proc Natl Acad Sci U S A (1994) 2.74

Sequence and genome organization of Borna disease virus. J Virol (1994) 2.41

Borna disease virus (BDV), a nonsegmented RNA virus, replicates in the nuclei of infected cells where infectious BDV ribonucleoproteins are present. J Virol (1994) 1.93

Molecular biology of borna disease virus: prototype of a new group of animal viruses. J Virol (1994) 1.83

Sequence conservation in field and experimental isolates of Borna disease virus. J Virol (1994) 1.67

RNA splicing in Borna disease virus, a nonsegmented, negative-strand RNA virus. J Virol (1994) 1.50

Identification of signal sequences that control transcription of borna disease virus, a nonsegmented, negative-strand RNA virus. J Virol (1994) 1.30

Characterization of a Borna disease virus glycoprotein, gp18. J Virol (1994) 1.23

Biochemical and functional analysis of the Borna disease virus G protein. J Virol (1997) 1.12

Neutralizing antibodies in Borna disease virus-infected rats. J Virol (1995) 1.10

Two proline-rich nuclear localization signals in the amino- and carboxyl-terminal regions of the Borna disease virus phosphoprotein. J Virol (1998) 1.09

Molecular basis for the differential subcellular localization of the 38- and 39-kilodalton structural proteins of Borna disease virus. J Virol (1997) 1.07

Detection and sequence analysis of borna disease virus p24 RNA from peripheral blood mononuclear cells of patients with mood disorders or schizophrenia and of blood donors. J Virol (1998) 0.99

Borna disease virus nucleoprotein requires both nuclear localization and export activities for viral nucleocytoplasmic shuttling. J Virol (2001) 0.98

Borna disease virus: immunoelectron microscopic characterization of cell-free virus and further information about the genome. J Virol (1994) 0.97

A reverse-type sandwich enzyme-linked immunosorbent assay for detecting antibodies to Borna disease virus. J Clin Microbiol (1997) 0.92

Modulation of Borna disease virus phosphoprotein nuclear localization by the viral protein X encoded in the overlapping open reading frame. J Virol (2003) 0.90

Evidence for translation of the Borna disease virus G protein by leaky ribosomal scanning and ribosomal reinitiation. J Virol (1997) 0.85

Lack of association of Borna disease virus and human T-cell leukemia virus type 1 infections with psychiatric disorders among Japanese patients. Clin Diagn Lab Immunol (1997) 0.84

Articles by these authors

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76

On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology (1978) 9.02

Activation of influenza A viruses by trypsin treatment. Virology (1975) 8.07

Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology (1976) 4.85

Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci U S A (1985) 4.66

Influenza virus A pathogenicity: the pivotal role of hemagglutinin. Cell (1987) 4.34

Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. Science (1985) 4.31

Evaluation of the E test, a novel method of quantifying antimicrobial activity. J Antimicrob Chemother (1991) 4.06

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med (1992) 4.05

Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of Avian influenza viruses. Virology (1981) 3.83

Insertion mutations in the dam gene of Escherichia coli K-12. Mol Gen Genet (1983) 3.61

Interaction between the origin recognition complex and the replication licensing system in Xenopus. Cell (1996) 3.45

Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol (1986) 3.45

The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. Virology (1979) 3.25

Antigenic shift of visna virus in persistently infected sheep. Science (1977) 3.17

Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus. Nature (1989) 3.10

Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med (1972) 3.09

A deletion map of the human Y chromosome based on DNA hybridization. Am J Hum Genet (1986) 3.03

Functional significance of sialidose during influenza virus multiplication. Virology (1966) 2.94

The molecular biology of influenza virus pathogenicity. Adv Virus Res (1988) 2.90

Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. J Gen Virol (1982) 2.87

Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J Virol (1996) 2.86

Inhibition of glycoprotein biosynthesis of influenza virus by D-glucosamine and 2-deoxy-D-glucose. Virology (1972) 2.84

Selection of a fixative for identifying T cell subsets, B cells, and macrophages in paraffin-embedded mouse spleen. J Immunol Methods (1983) 2.82

Influenza viruses cause hemolysis and fusion of cells. Virology (1981) 2.73

Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci U S A (1999) 2.63

Force fluctuations in bead packs. Science (1995) 2.59

PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J Biol Chem (2000) 2.57

Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science (1985) 2.57

Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect Immun (1983) 2.52

Lentiviral diseases of sheep and goats: chronic pneumonia leukoencephalomyelitis and arthritis. Rev Infect Dis (1985) 2.51

Genetic relatedness between the new 1977 epidemic strains (H1N1) of influenza and human influenza strains isolated between 1947 and 1957 (H1N1). Virology (1978) 2.51

Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. Antiviral Res (2006) 2.43

Correlation between RNA fragments of fowl plague virus and their corresponding gene functions. Virology (1976) 2.36

Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J Virol (1997) 2.34

Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci U S A (1997) 2.34

Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virology (1990) 2.33

Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques. J Virol (1992) 2.30

Replication of Borna disease virus in cell cultures. Med Microbiol Immunol (1980) 2.24

CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc Natl Acad Sci U S A (1997) 2.23

Identification of a common antigen of herpes simplex virus bovine herpes mammillitis virus, and B virus. J Virol (1978) 2.16

Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage. Virology (1981) 2.13

Inhibition of the multiplication of enveloped RNA-viruses by glucosamine and 2-deoxy-D-glucose. J Gen Virol (1972) 2.12

Perfusion of the spleen with blood containing prostaglandin E1: transmitter liberation and uptake. Proc R Soc Lond B Biol Sci (1969) 2.11

Behavioral disease in rats caused by immunopathological responses to persistent borna virus in the brain. Science (1983) 2.10

Biology and pathogenesis of lentiviruses. J Gen Virol (1989) 2.09

High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol (1999) 2.08

Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology (1999) 2.07

LuSIV cells: a reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication. Virology (2000) 2.07

Genomic changes associated with antigenic variation of visna virus durig persistent infection. Proc Natl Acad Sci U S A (1980) 2.04

Association of influenza virus proteins with cytoplasmic fractions. Virology (1974) 2.00

A novel human protein serine/threonine phosphatase, which possesses four tetratricopeptide repeat motifs and localizes to the nucleus. EMBO J (1994) 1.98

Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector. EMBO J (1986) 1.98

Studies on the adaptation of influenza viruses to MDCK cells. EMBO J (1984) 1.98

The function of the neuraminidase in membrane fusion induced by myxoviruses. Virology (1980) 1.97

Role of Staphylococcus protease in the development of influenza pneumonia. Nature (1987) 1.96

Synthesis in vivo of influenza virus plus and minus strand RNA and its preferential inhibition by antibiotics. Virology (1970) 1.95

Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus. N Engl J Med (1973) 1.90

Molecular basis of infectivity and pathogenicity of myxovirus. Brief review. Arch Virol (1979) 1.89

Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques. Virology (1993) 1.89

Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J Virol (1997) 1.86

Studies of the antigenic relationships of the new human papovaviruses by electron microscopy agglutination. Infect Immun (1973) 1.84

Effect of manually assisted cough and mechanical insufflation on cough flow of normal subjects, patients with chronic obstructive pulmonary disease (COPD), and patients with respiratory muscle weakness. Thorax (2001) 1.84

Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J Virol (1997) 1.84

Generation of seal influenza virus variants pathogenic for chickens, because of hemagglutinin cleavage site changes. J Virol (1990) 1.81

Mutations at the cleavage site of the hemagglutinin after the pathogenicity of influenza virus A/chick/Penn/83 (H5N2). Virology (1989) 1.81

Antigenic variation in visna virus. Cell (1979) 1.81

Virus mutation during 'slow infection': temporal development and characterization of mutants of visna virus recovered from sheep. J Gen Virol (1978) 1.80

Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses. Proc Natl Acad Sci U S A (1986) 1.80

Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein. J Biol Chem (1994) 1.79

Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-R. Virology (1992) 1.79

Slow virus infection: replication and mechanisms of persistence of visna virus in sheep. J Infect Dis (1977) 1.78

Apoptosis and the cell cycle. Curr Opin Cell Biol (1995) 1.76

The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO J (1985) 1.76

Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res (1998) 1.76

A DNase for apurinic/apyrimidinic sites associated with exonuclease III of Hemophilus influenzae. J Biol Chem (1978) 1.75

The role of swine in the generation of novel influenza viruses. Zoonoses Public Health (2009) 1.74

cis- and trans-acting transcriptional regulation of visna virus. Science (1985) 1.74

Characterization of a cDNA clone encoding the visna virus transactivating protein. Proc Natl Acad Sci U S A (1989) 1.73

Fusion between cell membrane and liposomes containing the glycoproteins of influenza virus. Virology (1980) 1.73

Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden. Virology (1994) 1.73

The pathogenesis of viral leukoencephalomyelitis-arthritis of goats. I. Persistent viral infection with progressive pathologic changes. Lab Invest (1980) 1.72

The nucleic acid of an SV40-like virus isolated from a patient with progressive multifocal leukoencephalopathy. Virology (1973) 1.71

Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol (2000) 1.71

Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J Infect Dis (2001) 1.70

The 24K protein of Borna disease virus. J Gen Virol (1992) 1.69

Pathogenesis of human poliovirus infection in mice. I. Clinical and pathological studies. J Neuropathol Exp Neurol (1980) 1.68

Pathogenesis of Borna disease in rats: immune-mediated viral ophthalmoencephalopathy causing blindness and behavioral abnormalities. J Infect Dis (1983) 1.66